RT Journal Article
SR Electronic
T1 COVID-19 in Japan: What could happen in the future?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.21.20026070
DO 10.1101/2020.02.21.20026070
A1 Shao, Nian
A1 Xuan, Yan
A1 Pan, Hanshuang
A1 Wang, Shufen
A1 Li, Weijia
A1 Yan, Yue
A1 Li, Xingjie
A1 Shen, Christopher Y.
A1 Chen, Xu
A1 Luo, Xinyue
A1 Chen, Yu
A1 Xu, Boxi
A1 Liu, Keji
A1 Zhong, Min
A1 Xu, Xiang
A1 Jiang, Yu
A1 Lu, Shuai
A1 Ding, Guanghong
A1 Cheng, Jin
A1 Chen, Wenbin
YR 2020
UL http://medrxiv.org/content/early/2020/02/28/2020.02.21.20026070.abstract
AB COVID-19 has been impacting on the whole world critically and constantly Since December 2019. We have independently developed a novel statistical time delay dynamic model on the basis of the distribution models from CCDC. Based only on the numbers of confirmed cases in different regions in China, the model can clearly reveal that the containment of the epidemic highly depends on early and effective isolation. We apply the model on the epidemic in Japan and conclude that there could be a rapid outbreak in Japan if no effective quarantine measures are carried out immediately.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWenbin Chen was supported in part by the National Science Foundation of China (11671098, 91630309) and 111 project(B08018), Jin Cheng was supported in part by the National Science Foundation of China (11971121).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data from Wind database or any one can find them in the website of Chinese Center for Disease Control and Prevention(CCDC). Only the cumulative numbers in hospitalization are needed.